BGU researchers in Israel discovers a probiotic yogurt-based drug to combat Covid
BGU researchers in Israel discovers a probiotic yogurt-based drug to combat Covid
Share:

LONDON: A team of Israeli researchers have discovered new drug candidates from probiotic Kefir yogurt that may combat pathogenic bacteria and treat various inflammatory conditions, including inflammatory bowel disease and Covid-19 infections.

The study, led by researchers from the Ben-Gurion University of the Negev (BGU) in Israel, highlighted the mechanism by which milk fermented probiotics can protect against pathogenic infections and aid the immune system.

The findings, published in the journal Microbiome, showed that the kefir-secreted molecules can significantly reduce the virulence of Vibrio cholera, which causes cholera. The anti-bacterial effect was based on disrupting communication among the bacterial cells.

The drug candidates are based on molecules isolated from Kefir yogurt, ie. a fermented probiotic dairy drink made by infusing cow or goat milk with kefir grains containing yeast and lactic acid bacteria.

Further, the experimental results revealed that the isolated molecules effectively healed mice inflicted with a lethal "cytokine storm" -- the extreme immune response, which is one of the main causes of death in Covid-19 patients.

While the healthy properties of probiotics in yogurt have been widely recognised, the study showed how these actually have the potential to be highly effective drugs, the researchers said.

"These results are notable, since this is the first demonstration that virulence of human pathogenic bacteria can be mitigated by molecules secreted in probiotic milk products, such as yogurt or kefir," said Raz Jelinek, Professor at the BGU.

Read more about Probiotic:

The Probiotic Improves Nutrient Absorption in the malnourished

The Probiotic Improves Nutrient Absorption in the malnourished

LIFESTYLE- FOOD: Probiotics, Fermented Dairy Products

 

Join NewsTrack Whatsapp group
Related News